Skip to main content
OpenTrials
Completed

NCT Number: NCT01799356

Moxifloxacin Versus Ofloxacin Plus Metronidazole in Uncomplicated Pelvic Inflammatory Disease: Multicenter Randomized Controlled Trials

We aimed to compare efficacy and safety of combination therapy with oral ofloxacin, 400 mg twice daily, plus oral metronidazole, 500 mg twice daily, for 14 days, with moxifloxacin monotherapy, 400 mg once daily, for 14 days

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pelvic Inflammatory Disease Adnexal Diseases Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Genital Diseases Genital Diseases, Female Infections Pelvic Infection Urogenital Diseases

Age range

14 year–45 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 4

Primary location

T.C.S.B. İstanbul Training Research Hospital, Samatya, Fatih, Turkey (Türkiye)

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Women diagnosed uncomplicated PID
  • Patients age are between 14 with 45
  • Pelvic tenderness and vaginal discharge

Exclusion criteria

  • Urinary Tract Enfections
  • Tubo-ovarian abscess and complicated PID
  • Hıstory of antibiotics treatment
  • Other pelvic pain causes
  • Endometriosis
  • Delivery,abortion and surgery within last months

Treatment and study plan

moxifloxacin

Drug

daily 400 mg moksifloksasin

Other names: new generetaion flouroquinolon antibiotics

Ofloxacin

Drug

daily 800 mg oflaksasin plus 1000 mg metronidazol treatment

Other names: floroquinolon antibiotics

Metronidazole

Drug

daily 1000 mg metronidazol plus 800 mg oflaksasin treatment for uPID

Other names: anaerobic antibiotics

Primary outcomes

  1. Clinically cure

    Time frame: 21 Days

Secondary outcomes

  1. Microbiological cure

    Time frame: 21 Days

Sponsors and collaborators

Lead sponsor

Istanbul Bakirkoy Maternity and Children Diseases Hospital

Other Gov

Registry information

Important dates

Study start
2010
Primary completion
2013
Study completion
2013
First posted
Feb 26, 2013
Registry last updated
Aug 28, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.